Literature DB >> 228002

Mouse hybrid cell lines produce antibodies to herpes simplex virus type 1.

E L Howes, E A Clark, E Smith, N A Mitchison.   

Abstract

A solid-phase radioimmunoassay procedure has been devised for the assay of antibodies produced in the mouse to herpes simplex virus type 1 (HSV-1). It is based on the adsorption of virus to flexible micro-well plates and uses radio-iodine-labelled rabbit antibody against mouse immunoglobulin to assess antibody binding. Using this assay for screening, cell hybrids have been obtained which yield monoclonal antibody to HSV-1. The hybrids are between spleen cells from hyperimmune mice and an immunoglobulin-non-secreting, azaquanine resistant myeloma cell line (NS-1). From 480 hybrid cell lines initially examined, five stable cell lines were obtained which released HSV-1-specific antibody in vitro and in vivo. Mice carrying transplants of these cell lines yield binding titres in serum of up to 1/25000. Both IgG and IgM antibodies were obtained in this way.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 228002     DOI: 10.1099/0022-1317-44-1-81

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Report of twelve years experience in open study of Skinner herpes simplex vaccine towards prevention of herpes genitalis.

Authors:  G R Skinner; C Fink; J Melling; C Wiblin; B Thornton; J Hallworth; W Gardner; P McLeish; C Hartley; A Buchan
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

2.  Antibody reactivity with Skinner HSV vaccine.

Authors:  E M Muniu; J Durham; D Shariff; C E Hartley; A Fuller; J Melling; C Wiblin; G Wilkins; A Buchan; G R Skinner
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

3.  Genotyping of herpes simplex viruses by polymerase chain reaction.

Authors:  H Piiparinen; A Vaheri
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Production of monoclonal antibodies against nucleocapsid proteins of herpes simplex virus types 1 and 2.

Authors:  M Zweig; C J Heilman; H Rabin; R F Hopkins; R H Neubauer; B Hampar
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

5.  Follow-up report on 50 subjects vaccinated against herpes genitalis with Skinner vaccine.

Authors:  G R Skinner; C G Fink; M Cowan; A Buchan; A Fuller; C E Hartley; J Durham; C Wiblin; J Melling
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

Review 6.  Monoclonal antibodies against microorganisms.

Authors:  R A Polin
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

7.  The characterization and purification of DNA binding proteins present within herpes simplex virus infected cells using monoclonal antibodies.

Authors:  N B la Thangue; W L Chan
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

8.  Production of antibodies against measles virions by use of the mouse hybridoma technique.

Authors:  T Togashi; C Orvell; F Vartdal; E Norrby
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

9.  Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen.

Authors:  G J Hoffman; S G Lazarowitz; S D Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

10.  Identification of the pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodies.

Authors:  M Eloit; D Fargeaud; R L'Haridon; B Toma
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.